These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 20033474)

  • 21. Comparative studies on the properties of glycyrrhetinic acid-loaded PLGA microparticles prepared by emulsion and template methods.
    Wang H; Zhang G; Sui H; Liu Y; Park K; Wang W
    Int J Pharm; 2015 Dec; 496(2):723-31. PubMed ID: 26581771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Poly(ethylene glycol)-modified proteins: implications for poly(lactide-co-glycolide)-based microsphere delivery.
    Pai SS; Tilton RD; Przybycien TM
    AAPS J; 2009 Mar; 11(1):88-98. PubMed ID: 19199044
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.
    Péan JM; Venier-Julienne MC; Boury F; Menei P; Denizot B; Benoit JP
    J Control Release; 1998 Dec; 56(1-3):175-87. PubMed ID: 9801441
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres.
    Lam XM; Duenas ET; Cleland JL
    J Pharm Sci; 2001 Sep; 90(9):1356-65. PubMed ID: 11745788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and characterization of doxorubicin-loaded poly(lactide-co-glycolide) nanoparticles as a sustained-release anticancer drug delivery system.
    Amjadi I; Rabiee M; Hosseini MS; Mozafari M
    Appl Biochem Biotechnol; 2012 Nov; 168(6):1434-47. PubMed ID: 22976852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antitumor Efficacy and Toxicity of 5-Fluorouracil-Loaded Poly(Lactide Co-glycolide) Pellets.
    Leelakanok N; Geary SM; Salem AK
    J Pharm Sci; 2018 Feb; 107(2):690-697. PubMed ID: 29031952
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Manufacturing dexamethasone intravitreal implants: Process control and critical quality attributes.
    Costello MA; Liu J; Wang Y; Qin B; Xu X; Li Q; Smith WC; Lynd NA; Zhang F
    Int J Pharm; 2023 Nov; 647():123515. PubMed ID: 37844672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. One-step production of protein-loaded PLGA microparticles via spray drying using 3-fluid nozzle.
    Wan F; Maltesen MJ; Andersen SK; Bjerregaard S; Foged C; Rantanen J; Yang M
    Pharm Res; 2014 Aug; 31(8):1967-77. PubMed ID: 24549821
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of the test method on in vitro drug release from intravitreal model implants containing dexamethasone or fluorescein sodium in poly (d,l-lactide-co-glycolide) or polycaprolactone.
    Stein S; Auel T; Kempin W; Bogdahn M; Weitschies W; Seidlitz A
    Eur J Pharm Biopharm; 2018 Jun; 127():270-278. PubMed ID: 29490233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysozyme microencapsulation within biodegradable PLGA microspheres: urea effect on protein release and stability.
    Nam YS; Song SH; Choi JY; Park TG
    Biotechnol Bioeng; 2000 Nov; 70(3):270-7. PubMed ID: 10992231
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel in vitro delivery system for assessing the biological integrity of protein upon release from PLGA microspheres.
    Aubert-Pouëssel A; Bibby DC; Venier-Julienne MC; Hindré F; Benoît JP
    Pharm Res; 2002 Jul; 19(7):1046-51. PubMed ID: 12180538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced antitumor efficacy of poly(D,L-lactide-co-glycolide)-based methotrexate-loaded implants on sarcoma 180 tumor-bearing mice.
    Gao L; Xia L; Zhang R; Duan D; Liu X; Xu J; Luo L
    Drug Des Devel Ther; 2017; 11():3065-3075. PubMed ID: 29118572
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulated release of IdUrd from poly (D,L-lactide-co-glycolide) microspheres by addition of poly (D,L-lactide) oligomers.
    Geze A; Venier-Julienne MC; Saulnier P; Varlet P; Daumas-Duport C; Devauchelle P; Benoit JP
    J Control Release; 1999 Apr; 58(3):311-22. PubMed ID: 10099156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Release of diclofenac sodium from polylactide-co-glycolide 80/20 rods.
    Viitanen P; Suokas E; Törmälä P; Ashammakhi N
    J Mater Sci Mater Med; 2006 Dec; 17(12):1267-74. PubMed ID: 17143758
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmaceutical and immunological evaluation of a single-shot hepatitis B vaccine formulated with PLGA microspheres.
    Shi L; Caulfield MJ; Chern RT; Wilson RA; Sanyal G; Volkin DB
    J Pharm Sci; 2002 Apr; 91(4):1019-35. PubMed ID: 11948541
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Silica particles incorporated into PLGA-based in situ-forming implants exploit the dual advantage of sustained release and particulate delivery.
    Thalhauser S; Peterhoff D; Wagner R; Breunig M
    Eur J Pharm Biopharm; 2020 Nov; 156():1-10. PubMed ID: 32860903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of process stress on protein stability in highly-loaded solid protein/PEG formulations from small-scale melt extrusion.
    Dauer K; Werner C; Lindenblatt D; Wagner KG
    Int J Pharm X; 2023 Dec; 5():100154. PubMed ID: 36632069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formulation and in vitro-in vivo evaluation of black raspberry extract-loaded PLGA/PLA injectable millicylindrical implants for sustained delivery of chemopreventive anthocyanins.
    Desai KG; Olsen KF; Mallery SR; Stoner GD; Schwendeman SP
    Pharm Res; 2010 Apr; 27(4):628-43. PubMed ID: 20148292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Poly (DL-lactide-co-glycolide) (PLGA) nanoparticles with entrapped trans-cinnamaldehyde and eugenol for antimicrobial delivery applications.
    Gomes C; Moreira RG; Castell-Perez E
    J Food Sci; 2011 Mar; 76(2):N16-24. PubMed ID: 21535781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of formulation parameters on the characteristics of poly(D, L-lactide-co-glycolide) microspheres containing poly(L-lysine) complexed plasmid DNA.
    Capan Y; Woo BH; Gebrekidan S; Ahmed S; DeLuca PP
    J Control Release; 1999 Aug; 60(2-3):279-86. PubMed ID: 10425333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.